Trogenix Ltd

About Trogenix Ltd

Trogenix is a biotechnology company focused on revolutionizing cancer treatment through precision therapies. Their mission is to develop curative, one-time treatments for aggressive cancers using their proprietary gene therapy platform, Odysseus(r), and Synthetic Super-Enhancers (SSEs) technology, which selectively target diseased cells while sparing healthy tissue.

Products & Services

Odysseus(r) Platform:A proprietary gene therapy platform designed to develop precision cancer treatments that target diseased cell states, reveal cancer to the immune system, and kill tumor cells.

Synthetic Super-Enhancers (SSEs):Engineered DNA elements activated only in diseased cell states, acting as docking stations for transcription factors in aggressive cancer cells, enabling selective and potent gene control.

Precision Therapies:Therapies that selectively treat cancer cells without toxicity to healthy tissue, combining controlled cell killing, immune modulation, and long-term protection against recurrence.

Specialties

Precision Cancer Therapies Gene Therapy Synthetic Super-Enhancers (SSEs) Immunotherapy Solid Tumors Treatment Regenerative Medicine

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series A T: - FT: Series A	A: 95000000 MR: - FA: $95 million FAN: 95000000	D: 2025-10-06 FD: 2025-10-06	9 investors

Series A Latest

2025-10-06

$95.0M

9 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

P

Prof. Steve Pollard

CSO and Founder

D

Dr. Ken Macnamara

CEO

D

Dr. Dima Kuzmin

Chairman

D

Dr. Juan Manuel Iglesias

CTO

T

Tay Salimullah

CSO and Board Member

A

Atif Abbas, MD

CMO

View 33 more team members with Pro

Unlock Full Team Directory

Recent News

Trogenix Ltd Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised